Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1306-1312
doi: 10.1161/hq0801.093507
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuda, K.
Right arrow Articles by Masuyama, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsuda, K.
Right arrow Articles by Masuyama, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(D)-PENICILLAMINE
*(L)-ARGININE
*ESTRADIOL
*NITRIC OXIDE
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Clinical Studies
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:1306.)
© 2001 American Heart Association, Inc.


Vascular Biology

Electron Paramagnetic Resonance Investigation on Modulatory Effect of 17ß-Estradiol on Membrane Fluidity of Erythrocytes in Postmenopausal Women

Kazushi Tsuda; Yukiko Kinoshita; Keizo Kimura; Ichiro Nishio; Yoshiaki Masuyama

From the Division of Cardiology (K.T., Y.K., K.K., I.N.), Department of Medicine, Wakayama Medical University, Wakayama, Japan, and Tokyo Rosai Hospital (Y.M.), Tokyo, Japan.

Correspondence to Kazushi Tsuda, MD, Division of Cardiology, Department of Medicine, Wakayama Medical University, Kimiidera 811-1, Wakayama 641-8509, Japan. E-mail tsudak{at}mail.wakayama-med.ac.jp

Abstract— Many studies have shown that estrogen may exert cardioprotective effects and reduce the risk of hypertension and coronary events. On the other hand, it has been proposed that cell membrane abnormalities play a role in the pathophysiology of hypertension, although it is not clear whether estrogen would influence membrane function in essential hypertension. The present study was performed to investigate the effects of 17ß-estradiol (E2) on membrane fluidity of erythrocytes in normotensive and hypertensive postmenopausal women. We determined the membrane fluidity of erythrocytes by means of an electron paramagnetic resonance and spin-labeling method. In an in vitro study, E2 significantly decreased the order parameter for 5-nitroxide stearate and the peak height ratio for 16-nitroxide stearate obtained from electron paramagnetic resonance spectra of erythrocyte membranes in normotensive postmenopausal women. The finding indicates that E2 might increase the membrane fluidity of erythrocytes. The effect of E2 was significantly potentiated by the NO donor, S-nitroso-N-acetylpenicillamine, and a cGMP analogue, 8-bromo-cGMP. In contrast, the change in the membrane fluidity evoked by E2 was attenuated in the presence of the NO synthase inhibitor, NG-nitro-L-arginine methyl ester, and asymmetric dimethyl-L-arginine. In hypertensive postmenopausal women, the membrane fluidity of erythrocytes was significantly lower than that in normotensive postmenopausal women. The effect of E2 on membrane fluidity was significantly more pronounced in the erythrocytes of hypertensive postmenopausal women than in the erythrocytes of normotensive postmenopausal women. The results of the present study showed that E2 significantly increased the membrane fluidity and improved the microviscosity of erythrocyte membranes, partially mediated by an NO- and cGMP-dependent pathway. Furthermore, the greater action of E2 in hypertension might be consistent with the hypothesis that E2 could have a beneficial effect in regulating rheological behavior of erythrocytes and could have a crucial role in the improvement of the microcirculation in hypertension.


Key Words: 17ß-estradiol • nitric oxide • membrane fluidity • erythrocytes • postmenoapusal women




This article has been cited by other articles:


Home page
Biophys. JHome page
S. Leekumjorn, Y. Wu, A. K. Sum, and C. Chan
Experimental and Computational Studies Investigating Trehalose Protection of HepG2 Cells from Palmitate-Induced Toxicity
Biophys. J., April 1, 2008; 94(7): 2869 - 2883.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda
Sex Hormones and Stroke Rehabilitation in Men and Women
Stroke, June 1, 2007; 38(6): e32 - e32.
[Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda
Asymmetric Dimethylarginine and Cerebrovascular Disorders in Humans
Stroke, December 1, 2006; 37(12): 2870 - 2870.
[Full Text] [PDF]


Home page
HypertensionHome page
K. Tsuda
A New Hormone Therapy With Drospirenone and NO Production in Postmenopausal Women
Hypertension, November 1, 2006; 48(5): e106 - e106.
[Full Text] [PDF]


Home page
HypertensionHome page
K. Tsuda
Surgical Menopause, Salt Sensitivity, and NO Bioavailability in Women
Hypertension, September 1, 2006; 48(3): E12 - E12.
[Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda
Sex Hormones and Carotid Atherosclerosis in the Metabolic Syndrome
Stroke, December 1, 2005; 36(12): 2528 - 2528.
[Full Text] [PDF]


Home page
CirculationHome page
K. Tsuda, I. Nishio, E. Ros, I. Nunez, A. Perez-Heras, M. Serra, R. Gilabert, E. Casals, and R. Deulofeu
Modulation of Endothelial Function by Walnuts and Sex Hormones * Response
Circulation, August 17, 2004; 110(7): e73 - e73.
[Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda, I. Nishio, P. J. Kelly, and K. L. Furie
Homocysteine, Vitamin B6, and Endothelial Dysfunction in Circulatory Disorders * Response
Stroke, August 1, 2004; 35(8): 1785 - 1785.
[Full Text] [PDF]


Home page
CirculationHome page
K. Tsuda and I. Nishio
Serum Homocysteine and Endothelial Dysfunction in Circulatory Disorders in Women
Circulation, July 27, 2004; 110(4): e37 - e37.
[Full Text] [PDF]


Home page
CirculationHome page
K. Tsuda, I. Nishio, M. Weis, J. P. Cooke, K. Y. Lin, S. N. Panchal, S.Z. Gao, H. A. Valantine, T. N. Kledal, and E. S. Mocarski
Sex Hormones and Asymmetric Dimethylarginine in Transplant Arteriosclerosis * Response
Circulation, July 20, 2004; 110(3): e21 - e22.
[Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda and I. Nishio
Hyperinsulinemia and Estrogen-Deficiency as Risk Factors for Stroke in Women
Stroke, June 1, 2004; 35(6): e134 - e134.
[Full Text] [PDF]


Home page
CirculationHome page
K. Tsuda, I. Nishio, V. Vaccarino, Z. Q. Lin, J. A. Mattera, S. A. Roumanis, S. V. Kasl, J. L. Abramson, and H. M. Krumholz
Sex Hormones and Membrane Microviscosity in Elderly Women * Response
Circulation, May 11, 2004; 109(18): e218 - e218.
[Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda, I. Nishio, T. Kurth, and J. E. Buring
Smoking, Estrogen, and Membrane Microviscosity in Women * Response
Stroke, April 1, 2004; 35(4): e71 - e71.
[Full Text] [PDF]


Home page
CirculationHome page
K. Tsuda, I. Nishio, D. P. Holden, J. E. Cartwright, G. St.J. Whitley, and S. S. Nussey
Estrogen and Asymmetric Dimethylarginine in Postmenopausal Women * Response
Circulation, March 30, 2004; 109(12): e174 - e174.
[Full Text] [PDF]


Home page
CirculationHome page
K. Tsuda, I. Nishio, J. P. Cooke, and M. Stuhlinger
Asymmetric Dimethylarginine and Circulatory Disorders in Postmenopausal Women * Response
Circulation, February 10, 2004; 109 (5): e35 - e35.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. Tsuda and I. Nishio
Role of Estrogens in the Regulation of Membrane Microviscosity
Circ. Res., February 6, 2004; 94 (2): e17 - e17.
[Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda, M. E. Mussolino, J. H. Madans, and R.F. Gillum
Bone Mineral Density, Blood Pressure, and Stroke in Elderly Women * Response
Stroke, November 1, 2003; 34 (11): e210 - e211.
[Full Text] [PDF]